gemtuzumab ozogamycin - Søgeresultater

perjeta-herceptin solution

hoffmann-la roche limited - pertuzumab; trastuzumab - solution - 420mg; 440mg - pertuzumab 420mg; trastuzumab 440mg - antineoplastic agents

Canada - engelsk - Health Canada

mabcampath solution

genzyme corporation - alemtuzumab - solution - 10mg - alemtuzumab 10mg - antineoplastic agents

Canada - engelsk - Health Canada

mabcampath solution

sanofi genzyme, a division of sanofi-aventis canada inc - alemtuzumab - solution - 30mg - alemtuzumab 30mg - antineoplastic agents

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

phesgo sc pertuzumab (rch) 600 mg and trastuzumab (rch) 600mg in 10ml solution for injection, vials

roche products pty ltd - pertuzumab, quantity: 600 mg; trastuzumab, quantity: 600 mg; water for injections, quantity: 10 ml - injection, solution - excipient ingredients: polysorbate 20; sucrose; histidine; trehalose dihydrate; vorhyaluronidase alfa; histidine hydrochloride monohydrate; methionine - early breast cancer (ebc),phesgo is indicated in combination with chemotherapy for the:,? neoadjuvant treatment of patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer (either >2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer,? adjuvant treatment of patients with her2-positive early breast cancer at high risk of recurrence,select patients for therapy based on a validated test.,metastatic breast cancer (mbc),phesgo is indicated in combination with docetaxel for patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease. select patients for therapy based on a validated test.

Kenya - engelsk - Pharmacy and Poisons Board

perjeta 420mg concentrate for solution for infusion

f. hoffman-la roche ltd, basel grenzacherstrasse 124 ch-4070 basel, switzerland - pertuzumab - concentrate for solution for infusion - one 14 ml vial of concentrate contains 420 mg of… - pertuzumab